It is recommended that physicians screen for prostate cancer with a digital rectal exam and prostate-specific antigen (PSA) level before starting therapy, and monitor PSA and hematocrit levels closely during therapy.
Recoméndase que os médicos busquen un cáncer de próstata cun exame rectal dixital e unha comprobación dos niveis de PSA (antíxeno prostático específico) antes de empezar a terapia, e monitorear de preto os niveis de PSA e hematocrito durante a terapia.